Apex Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | $5.62M | Buy |
200,997
+34,658
| +21% | +$969K | 0.12% | 147 |
|
|
2015
Q4 | $5.93M | Buy |
166,339
+12,513
| +8% | +$446K | 0.13% | 143 |
|
|
2015
Q3 | $5.09M | Buy |
153,826
+14,021
| +10% | +$464K | 0.12% | 145 |
|
|
2015
Q2 | $5.86M | Buy |
139,805
+11,375
| +9% | +$476K | 0.13% | 138 |
|
|
2015
Q1 | $4.19M | Buy |
128,430
+34,903
| +37% | +$1.14M | 0.1% | 161 |
|
|
2014
Q4 | $2.97M | Buy |
93,527
+22,445
| +32% | +$713K | 0.08% | 166 |
|
|
2014
Q3 | $1.76M | Buy |
71,082
+7,107
| +11% | +$176K | 0.05% | 174 |
|
|
2014
Q2 | $1.45M | Buy |
63,975
+8,791
| +16% | +$199K | 0.04% | 180 |
|
|
2014
Q1 | $1.34M | Buy |
+55,184
| New | +$1.34M | 0.05% | 183 |
|